How We Approach Intraocular Retinoblastoma in 2026: Agreement and Disagreement in Four Referral Centers in the USA and Europe.

Abramson DH, Shields CL, Munier FL, Chantada G

Open source

DOI
10.1002/1545-5017.70401
Published
2026 Aug
Container
Pediatric blood & cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/1545-5017.70401,
  title = {How We Approach Intraocular Retinoblastoma in 2026: Agreement and Disagreement in Four Referral Centers in the USA and Europe.},
  author = {Abramson DH and Shields CL and Munier FL and Chantada G},
  year = {2026},
  journal = {Pediatric blood \& cancer},
  doi = {10.1002/1545-5017.70401},
  url = {https://doi.org/10.1002/1545-5017.70401}
}

RIS

TY  - JOUR
TI  - How We Approach Intraocular Retinoblastoma in 2026: Agreement and Disagreement in Four Referral Centers in the USA and Europe.
AU  - Abramson DH
AU  - Shields CL
AU  - Munier FL
AU  - Chantada G
PY  - 2026
JO  - Pediatric blood & cancer
DO  - 10.1002/1545-5017.70401
UR  - https://doi.org/10.1002/1545-5017.70401
ER  - 

APA

DH, A., CL, S., FL, M., & G, C. (2026). How We Approach Intraocular Retinoblastoma in 2026: Agreement and Disagreement in Four Referral Centers in the USA and Europe.. Pediatric blood & cancer. https://doi.org/10.1002/1545-5017.70401

Source records